Generated: April 25, 2017
Which drugs does patent RE43932 protect, and when does it expire?
|Title:||Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use|
|Abstract:||The invention relates to a new crystalline form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-yl-methyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin- -2-ylamino)phenyl]-benzamide of formula I, which may be used for example for tumour therapy. ##STR00001##|
|Inventor(s):||Zimmermann; Juerg (Basel, CH), Sutter; Bertrand (Hesingue, FR), Buerger; Hans Michael (Allschwil, CH)|
|Assignee:||Novartis AG (Basel, CH)|
Patent Claim Types:|
see list of patent claims
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|CAPSULE;ORAL||021335-001||May 10, 2001||DISCN||Yes||No||RE43932*PED||► Subscribe|
|CAPSULE;ORAL||021335-002||May 10, 2001||DISCN||Yes||No||RE43932*PED||► Subscribe|
|TABLET;ORAL||021588-001||Apr 18, 2003||AB||RX||Yes||No||RE43932*PED||► Subscribe|
|TABLET;ORAL||021588-002||Apr 18, 2003||AB||RX||Yes||Yes||RE43932*PED||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|Switzerland||1764/97||Jul 18, 1997|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.